Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Daiichi Sankyo Ltd ADR
(OP:
DSNKY
)
29.58
+0.43 (+1.48%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,802,438
Open
29.49
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
29.15
Today's Range
29.29 - 29.99
52wk Range
23.72 - 37.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor
April 08, 2024
FDA approves Daiichi Sankyo's and AstraZeneca's Enhertu for unresectable or metastatic HER2+ solid tumors. Accelerated approval based on ORR and DOR. Boxed warnings for ILD/pneumonitis and embryo-fetal...
Via
Benzinga
Exposures
Product Safety
What's Going On With Pfizer Stock Today?
January 25, 2024
Pfizer to announce Q4 2023 earnings on 30th Jan. Analysts project EPS loss of $(0.22) and $14.25B in revenues.
Via
Benzinga
Performance
YTD
+9.19%
+9.19%
1 Month
-10.25%
-10.25%
3 Month
-0.30%
-0.30%
6 Month
+17.61%
+17.61%
1 Year
-17.31%
-17.31%
More News
Read More
Why Pharmaceutical Company Esperion Therapeutics Shares Are Diving Today
January 03, 2024
Via
Benzinga
Japan Emerges As Promising 2024 Investment Destination: 3 Stocks To Consider
December 20, 2023
Via
Benzinga
Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?
October 31, 2023
Via
The Motley Fool
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
March 20, 2023
Via
Benzinga
Daiichi Sankyo Seeks Approval In Japan For Its mRNA-Based COVID-19 Vaccine
January 13, 2023
Via
Benzinga
This Cancer Focused Stock Has 60% Potential Upside, Bullish Analyst Says
September 12, 2022
Via
Benzinga
Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting
September 22, 2023
Via
Benzinga
AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials
September 11, 2023
Via
Benzinga
FDA Greenlights Daiichi Sankyo's Blood Cancer Drug, A Promising Competitor to Novartis' Rydapt
July 21, 2023
Via
Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
July 04, 2023
Via
Benzinga
AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial
July 03, 2023
Via
Benzinga
Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines
June 27, 2023
Via
Benzinga
AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid Tumor Setting
March 06, 2023
Via
Benzinga
Is Gilead Sciences a Good Stock to Buy Now?
February 06, 2023
Via
The Motley Fool
AstraZeneca’s Next “Wonder Drug”
January 19, 2023
Via
Talk Markets
AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
December 19, 2022
Via
Benzinga
AstraZeneca Highlights First Results From Datopotamab Study In Pretreated Breast Cancer Patients
December 09, 2022
Via
Benzinga
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
November 14, 2022
Via
Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Via
Benzinga
3 Top Stocks to Invest In Right Now
August 16, 2022
Via
InvestorPlace
Seagen Suffers Loss In Arbitration Dispute Over ADC Technology
August 15, 2022
Via
Benzinga
AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study
August 15, 2022
Via
Benzinga
Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
August 12, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.